Denosumab biosimilar by Sandoz Group for Bone Metastasis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Bone Metastasis.

House Members Mull Bills to Cut Red Tape and Improve Docs’ Medicare Pay

A House hearing on ways to increase payments and cut red tape for physicians who treat Medicare patients also included a discussion over whether Republicans

October 21, 2023

Sucunamostat by Scohia Pharma for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 5, 2023

Cardiovascular health is intricately linked to the food security status of minoritized groups

The relationship between food security and ideal cardiovascular health while addressing disparities across minoritized groups.

May 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.